Description
This brand new title in the market-leading at a Glance series brings together fundamental information on cancer biology and treatment to provide a holistic understanding of oncology. It explores both relevant scientific content and key human issues, including communication and palliative care.
Oncology at a Glance:
• Provides an accessible overview of the scientific foundation of cancer medicine
• Covers the common cancers as well as key information on presentation and approaches to investigation and management
• Includes young adult oncology, the multidisciplinary team, clinical trials in oncology, approach to treatment and response assessment, management of nausea, and end-of-life care
• Was developed with students for students, to ensure it contains exactly what students need to know
Oncology at a Glance is an ideal guide for medical students and foundation-year doctors as well as any other healthcare professionals looking to consolidate their knowledge of oncology.
This title is also available as a mobile App from MedHand Mobile Libraries. Buy it now from Google Play or the MedHand Store.
Chapter
4: The hallmarks of cancer I
pp.:
16 – 18
5: The hallmarks of cancer II
pp.:
18 – 20
6: The hallmarks of cancer III
pp.:
20 – 22
7: The hallmarks of cancer IV
pp.:
22 – 24
8: Cancer genetics and inherited cancer
pp.:
24 – 26
9: Communicating with cancer patients
pp.:
26 – 28
10: Presenting problems in a patient with cancer
pp.:
28 – 30
11: Paraneoplastic syndromes
pp.:
30 – 32
12: Metabolic emergencies in cancer patients
pp.:
32 – 34
13: Oncological emergencies
pp.:
34 – 36
14: Investigation and management of metastatic disease
pp.:
36 – 38
15: Tumour markers
pp.:
38 – 40
16: Screening for cancer
pp.:
40 – 42
17: Imaging in oncology
pp.:
42 – 44
18: Approach to treatment and response assessment
pp.:
44 – 46
19: Principles of surgical oncology
pp.:
46 – 48
20: Pharmacology of anticancer agents
pp.:
48 – 50
21: Principles of radiotherapy
pp.:
50 – 52
22: Adverse effects of treatment
pp.:
52 – 54
23: Management of nausea
pp.:
54 – 56
24: Analgesia
pp.:
56 – 58
25: Clinical trials in cancer patients
pp.:
58 – 60
26: The role of multidisciplinary teams
pp.:
60 – 62
27: End of life care
pp.:
62 – 64
28: Carcinoma of unknown primary
pp.:
64 – 66
29: Breast cancer
pp.:
66 – 68
30: Lung cancer
pp.:
68 – 70
31: Mesothelioma
pp.:
70 – 72
32: Oesophageal cancer
pp.:
72 – 74
33: Gastric cancer
pp.:
74 – 76
34: Colorectal cancer
pp.:
76 – 78
35: Pancreatic cancer
pp.:
78 – 80
36: Hepatobiliary cancer
pp.:
80 – 82
37: Ovarian cancer
pp.:
82 – 84
38: Endometrial cancer
pp.:
84 – 86
39: Cervical cancer
pp.:
86 – 88
40: Germ cell tumours
pp.:
88 – 90
41: Prostate cancer
pp.:
90 – 92
42: Bladder and renal cancer
pp.:
92 – 94
43: Head and neck cancer
pp.:
94 – 96
44: Thyroid cancer
pp.:
96 – 98
45: Bone cancer and sarcoma
pp.:
98 – 100
46: Skin cancer
pp.:
100 – 102
47: Cancers of the central nervous system
pp.:
102 – 104
48: Neuroendocrine tumours
pp.:
104 – 106
49: Leukaemia
pp.:
106 – 108
50: Hodgkin’s lymphoma
pp.:
108 – 110
51: Non-Hodgkin’s lymphoma
pp.:
110 – 112
52: Myeloma
pp.:
112 – 114
53: Childhood cancers
pp.:
114 – 116
Case studies and questions
pp.:
116 – 120
Answers to case studies
pp.:
120 – 124